NCT00005928View on ClinicalTrials.gov

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

February 28, 2002

Conditions
AtherosclerosisCoronary DiseaseVasculitis
Interventions
DRUG

Ramipril

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00005928 - Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation | Biotech Hunter | Biotech Hunter